221 Digital assessment of stromal B cell aggregates as a biomarker of response to immune checkpoint inhibition in unresectable melanoma

• Katherine S Panageas,
• Yanyun Li,
• Margaret K Callahan,
• James W Smithy,
• Andrea P Moy,
• Ronglai Shen,
• Fiona Ehrich,
• Colleen Maher,
• Jasme Lee,
• Xiyu Peng,
• Nathaniel Aleynick,
• Mingqiang Zhuang,
• Travis Hollmann

Affiliations

Katherine S Panageas

4Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, USA

Yanyun Li

Memorial Sloan-Kettering Cancer Center, New York, NY, USA

Margaret K Callahan

Memorial Sloan-Kettering Cancer Center, New York, NY, USA

James W Smithy

Memorial Sloan-Kettering Cancer Center, New York, NY, USA

Andrea P Moy

Memorial Sloan-Kettering Cancer Center, New York, NY, USA

Ronglai Shen

Memorial Sloan-Kettering Cancer Center, New York, NY, USA

Fiona Ehrich

Memorial Sloan-Kettering Cancer Center, New York, NY, USA

Colleen Maher

Memorial Sloan-Kettering Cancer Center, New York, NY, USA

Jasme Lee

Memorial Sloan-Kettering Cancer Center, New York, NY, USA

Xiyu Peng

Memorial Sloan-Kettering Cancer Center, New York, NY, USA

Nathaniel Aleynick

Memorial Sloan-Kettering Cancer Center, New York, NY, USA

Mingqiang Zhuang

Memorial Sloan-Kettering Cancer Center, New York, NY, USA

Travis Hollmann

Memorial Sloan-Kettering Cancer Center, New York, NY, USA